Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2,2-diphosphonoethyl)(dodecyl)dimethylphosphonium
- Development stage
- Unknown
- Lead developer
- National Taiwan University
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
(2,2-diphosphonoethyl)(dodecyl)dimethylphosphonium is a synthetic small molecule belonging to the bisphosphonate class of compounds[1][2]. Bisphosphonates are characterized by two phosphonate groups and are known for their ability to inhibit enzymes involved in isoprenoid biosynthesis. This compound has been studied as an inhibitor of geranylgeranyl diphosphate synthase (GGPPS), an enzyme critical for protein prenylation pathways that are important in cancer cell proliferation and survival[6]. The mechanism involves binding to the substrate and/or product sites of GGPPS, interfering with its function. While structurally related to other bisphosphonates used clinically for bone diseases, this compound is primarily experimental and has been investigated mainly in biochemical and structural studies as a potential anticancer agent targeting GGPPS[6].
- Other names
- (2,2-diphosphonoethyl)(dodecyl)dimethylphosphonium
02
Targets
GGPPS1 (Geranylgeranyl pyrophosphate synthase)
Beyond the preview
Go deeper on (2,2-diphosphonoethyl)(dodecyl)dimethylphosphonium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2,2-diphosphonoethyl)(dodecyl)dimethylphosphonium.